Max Planck Team Maps Cell-Surface Sugar Code at Nanometre Resolution, Revealing Cancer and Immune Signatures
Scientists have developed Glycan Atlasing, a super-resolution technique that reads shifting sugar patterns on cell surfaces to distinguish cancer stages from healthy tissue and activated from resting immune cells.
Editor's Note ·
- Correction:
- The article states 'First authors Yurekli and Hashem described the significance…', characterising Nazlican Yurekli and Reem Hashem as first authors. According to the published Nature Nanotechnology paper (DOI: 10.1038/s41565-026-02151-y), the co-first authors who contributed equally are Dijo Moonnukandathil Joseph and Nazlican Yurekli. Reem Hashem is a co-author but is not listed as a first author. The quote attributed to Yurekli and Hashem is verbatim and correctly sourced; only the 'first authors' characterisation is inaccurate.
Overview
Every human cell is wrapped in a thin sugar coating called the glycocalyx — a constantly shifting molecular layer that mediates interactions with its environment. Scientists at the Max Planck Institute for the Science of Light have now shown that the nanoscale arrangement of those sugars is not random: it encodes information about whether a cell is healthy, cancerous, or immunologically active. The team’s new technique, called Glycan Atlasing, uses state-of-the-art super-resolution microscopy to read those patterns at the level of individual sugar molecules, and the results, published in Nature Nanotechnology in May 2026, suggest a potential path toward earlier disease detection.
What We Know
The study was led by Dijo Moonnukandathil Joseph in the Physical Glycosciences research group, headed by Prof. Leonhard Möckl at the Max Planck Institute for the Science of Light, according to ScienceDaily. Co-authors include Nazlican Yurekli, Reem Hashem, and nine other researchers.
Glycan Atlasing combines DNA-tagged lectin labelling and metabolic oligosaccharide engineering with advanced super-resolution microscopy — achieving ångström-scale resolution of approximately 9 Å — to produce atlas-like maps of glycan architecture across diverse cell types, according to Nanotechnology World. The researchers mapped cell culture lines, primary human blood cells, and tissue samples, as reported by ScienceDaily.
Phys.org reports that Glycan Atlasing is the first technique to demonstrate how the spatial arrangement of these structures relates to the cells’ physiological state. The method used lectin labeling and metabolic labeling targeting sialic acids to resolve glycan organisation at the cell surface.
Three capabilities were demonstrated in the study, according to Phys.org:
- Distinguishing activated from non-activated immune cells
- Identifying different cancer development stages
- Differentiating tumorous from non-tumorous areas in human breast tissue
The glycocalyx functions “almost like a display screen, showing information about a cell’s internal state on its outer surface,” according to ScienceDaily.
First authors Yurekli and Hashem described the significance in comments reported by Nanotechnology World: “We’ve known for a long time that glycans are important, but we’ve been largely blind to their spatial organization. This technology lets us see that the nanoscale arrangement itself carries functional information — it’s like discovering a new cellular language.”
What We Don’t Know
The study demonstrates proof-of-concept across cell cultures, blood cells, and tissue sections, but the team has not yet shown the method can be applied at the scale required for routine clinical diagnostics. The researchers worked with a limited number of samples and cell types. Large-scale validation across patient populations and disease conditions has not yet been conducted.
The study also does not establish whether glycan patterns can serve as standalone diagnostic biomarkers or whether they would need to be used alongside existing tests.
What Comes Next
Möckl outlined the team’s planned next steps in comments reported by ScienceDaily and NewKerala.com: “In large-scale studies, we want to investigate which surface patterns are associated with specific disease courses or therapeutic responses and how cell states can be detected early and objectively via the surface.”
The group plans to analyse additional target structures on the cell surface, automate the imaging and analysis pipeline, and expand to much larger sample cohorts — steps that would be necessary before adapting the technique for routine medical use.
Möckl described the results as “a promising foundation for the development of future diagnostic methods, as Glycan Atlasing delivers reliable results even in complex samples.”
Analysis
The significance of Glycan Atlasing lies in a conceptual shift: the glycocalyx has long been recognised as biologically important but remained largely opaque to structural analysis in live cellular contexts. By demonstrating that the spatial arrangement of surface sugars is not random but reflects cell state, the Max Planck team opens a new class of molecular readout — one that sits at the cell surface and could in principle be sampled from blood or tissue biopsies without needing to probe the cell’s interior.
The technique is also notable for what it maps alongside standard protein markers: cells that look similar by conventional protein-staining can exhibit distinct glycan patterns, meaning Glycan Atlasing may identify cellular states that existing methods miss entirely. If those differences prove diagnostically stable across patients and disease stages, the approach could eventually complement or refine current cancer staging and immune monitoring workflows.